Impact of molecular profiling on survival in patients with advanced biliary tract cancers

被引：1
|
作者：
Antoun, L. [1 ]
Deneche, I. [1 ]
Boileve, A. [2 ]
Tarabay, A. [2 ]
Rouleau, E. [1 ]
El Rawadi, E. [1 ]
Eid, R. [1 ]
Lacroix, L. [1 ]
Valery, M. [1 ]
Boige, V. [1 ]
Dartigues, P. [1 ]
Bani, M. [1 ]
Smolenschi, C. [2 ]
Scoazec, J. [1 ]
Ducreux, M. [1 ]
Hollebecque, A. [2 ]
Malka, D. [3 ]
机构：
[1] Gustave Roussy, Villejuif, France
[2] Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Mutualiste Montsouris, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SO-4
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [41] Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice
    Jain, Apurva
    Kwong, Lawrence N.
    Javle, Milind
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (11)
  • [42] A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC).
    Kim, Richard D.
    Kim, Dae Won
    Alese, Olatunji B.
    Li, Daneng
    Shah, Neal
    Schell, Michael J.
    Zhou, Jun Min
    Chung, Vincent
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
    Ikeda, Masafumi
    Ioka, Tatsuya
    Fukutomi, Akira
    Morizane, Chigusa
    Kasuga, Akiyoshi
    Takahashi, Hideaki
    Todaka, Akiko
    Okusaka, Takuji
    Creasy, Caretha L.
    Gorman, Shelby
    Felitsky, Daniel J.
    Kobayashi, Mikiro
    Zhang, Fanghong
    Furuse, Junji
    [J]. CANCER SCIENCE, 2018, 109 (01): : 215 - 224
  • [44] Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
    Jonathan D Mizrahi
    Valerie Gunchick
    Kabir Mody
    Lianchun Xiao
    Phanikeerthi Surapaneni
    Rachna T Shroff
    Vaibhav Sahai
    [J]. World Journal of Gastrointestinal Oncology, 2020, (01) : 83 - 91
  • [45] A Phase II Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Biliary Tract Cancers
    Den Linger, Crystal S.
    Meropol, Neal J.
    Li, Tianyu
    Lewis, Nancy L.
    Engstrom, Paul F.
    Weiner, Louis M.
    Cheng, Jonathan D.
    Alpaugh, R. Katherine
    Cooper, Harry
    Wright, John J.
    Cohen, Steven J.
    [J]. CLINICAL COLORECTAL CANCER, 2014, 13 (02) : 81 - 86
  • [46] Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
    Mizrahi, Jonathan D.
    Gunchick, Valerie
    Mody, Kabir
    Xiao, Lianchun
    Surapaneni, Phanikeerthi
    Shroff, Rachna T.
    Sahai, Vaibhav
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (01) : 83 - 91
  • [47] The clinical impact of c-MET over-expression in advanced biliary tract cancers
    Heo, Mi Hwa
    Kim, Seung Tae
    Park, Young Suk
    Park, Joon Oh
    Lee, Hansang
    [J]. CANCER RESEARCH, 2017, 77
  • [48] Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers
    Brechon, Marie
    Dior, Marie
    Dreanic, Johann
    Brieau, Bertrand
    Guillaumot, Marie-Anne
    Brezault, Catherine
    Mir, Olivier
    Goldwasser, Francois
    Coriat, Romain
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 156 - 162
  • [49] Skeletal muscle status and survival among patients with advanced biliary tract cancer
    Takaoka, Shinya
    Hamada, Tsuyoshi
    Takahara, Naminatsu
    Saito, Kei
    Endo, Go
    Hakuta, Ryunosuke
    Ishida, Kota
    Ishigaki, Kazunaga
    Kanai, Sachiko
    Kurihara, Kohei
    Oyama, Hiroki
    Saito, Tomotaka
    Sato, Tatsuya
    Suzuki, Tatsunori
    Suzuki, Yukari
    Tange, Shuichi
    Tokito, Yurie
    Tateishi, Ryosuke
    Nakai, Yousuke
    Fujishiro, Mitsuhiro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (03) : 248 - 257
  • [50] Survival by line of therapy of older patients with advanced biliary tract cancer (BTC)
    Bobiak, Sarah
    Danese, Mark D.
    Lubeck, Deborah P.
    Gleeson, Michelle L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345